The Power of Policy

What one policy change would accelerate progress in drug development and manufacturing? We asked the 2026 Power List.

1

Operational changes, such as faster clinical trial approvals, are critical for accelerating evidence generation and project funding.
2

Global harmonization of regulatory frameworks for advanced therapies could reduce costs and improve patient access.
3

Using biomarker-based trial endpoints may enable earlier drug approvals while maintaining safety and efficacy standards.
4

Policies should recognize the unique nature of cell and gene therapies, requiring tailored trial designs and payment models.
5

Reducing reliance on large animal testing in favor of human-relevant models could enhance drug development efficiency.

1